Navigation Links
Moffitt Cancer Center instrumental in new clinical guidelines for cancer-related fatigue
Date:5/30/2014

TAMPA, Fla. (May 30, 2014) Fatigue is a debilitating problem for cancer patients undergoing treatment; however, it also poses a huge detriment after treatment and can significantly affect quality of life. Approximately 30 percent of cancer patients endure persistent fatigue for several years after treatment, according to an American Society of Clinical Oncology Expert Panel co-chaired by Paul Jacobsen, Ph.D., associate center director of Population Sciences at Moffitt Cancer Center.

ASCO created the panel to develop assessment, screening, and treatment guidelines for medical professionals to help patients who experience fatigue after completing primary treatment. The panel analyzed several national guidelines from the United States and Canada, and reviewed published studies about cancer-related fatigue to create the new guidelines.

The panel recommends that all health care professions regularly screen and measure fatigue and other associated problems in cancer patients through health history, physical examinations, and laboratory analysis. It is important for all patients to be educated about fatigue and its associated medical problems.

Fatigue in cancer patients after treatment can arise from other problems, such as depression, pain, anxiety, nutritional deficits, medications, or emotional distress. The panel recommends that all contributing factors should be identified and treated before the symptoms of fatigue are addressed.

There are a number of treatment and care options for patients experiencing continued fatigue. "Studies show that initiating or maintaining adequate levels of physical activity can reduce cancer-related fatigue in post-treatment patients. Physicians should actively encourage all patients to engage in a moderate level of physical activity after cancer treatment, dependent on risk of injury," said Jacobsen.

Behavioral and psychoeducational therapies have also been reported to reduce fatigue in cancer patients. The panel recommends that patients interested in these options be referred to psychosocial service providers who specialize in cancer. Some studies also suggest that yoga, acupuncture and mindfulness-based approaches may also be beneficial.

The panel does not recommend medication to alleviate fatigue in cancer patients after treatment. While some data suggest that medication can help patients suffering from fatigue who have advanced disease or are receiving cancer treatment, there is insufficient evidence that these medications relieve fatigue in patients after treatment.

The new guidelines appeared in the April 14 issue of the Journal of Clinical Oncology.


'/>"/>

Contact: Kim Polacek
Kim.Polacek@moffitt.org
813-745-7408
H. Lee Moffitt Cancer Center & Research Institute
Source:Eurekalert

Related medicine news :

1. Moffitt Cancer Centers phase 3 study may be game-changer for acute myeloid leukemia
2. Moffitt Cancer Center begins Phase I clinical trial of new immunotherapy
3. Moffitt instrumental in FDA approval of revolutionary 2-drug combo to treat advanced melanoma
4. Moffitt Cancer Center launches prostate cancer study focused on black men
5. Single injection may revolutionize melanoma treatment, Moffitt study shows
6. Moffitt researchers identify gene variations that may help predict cancer treatment response
7. Moffitt Cancer Center expert standardizing guidelines for penile cancer treatment
8. Protein complex linked to cancer growth may also help fight tumors, Moffitt researchers say
9. Single men, smokers at higher risk for oral human papillomavirus infection, Moffitt study shows
10. How to boost Hispanics participation in clinical trials? Relate to them, Moffitt study shows
11. New screening approach identifies small proteins unique to melanoma cells, Moffitt researcher says
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports hinting at ... company to wait until March 2017 for an interest rate increase, according to Rajeev ... of Business. , “The Federal Open Market Committee (FOMC) dot charts are of interest ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... with discovery of thousands of defective respirators, according to court documents and SEC ... case of William and Becky Tyler v. American Optical Corporation, Case No. BC588866, ...
(Date:5/26/2016)... ... May 26, 2016 , ... Connor Sports, ... as a partner for the Tamika Catchings Legacy Tour that will commemorate ... leader in hardwood basketball surfaces in all forms and levels of the game, Connor ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... a significant negative impact on long-term patient survival, reports a team of UPMC ... online this week in the Journal of Thoracic and Cardiovascular Surgery, provide critical ...
(Date:5/26/2016)... ... May 26, 2016 , ... Catalent Pharma Solutions, the ... consumer health and global clinical supply services, today announced two key appointments and ... continued investment and strategic growth plans in the Asia Pacific region. , Howard ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... , Germany and ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime ... a licensing and co-development agreement with Therawis Diagnostics GmbH to ... will be to develop and market PITX2 as a marker ... other high-risk breast cancer patients. "We are pleased ...
(Date:5/25/2016)... 25, 2016 As illustrated by ... this month, the numbers and momentum of cannabis in ... into the billions, more research and development push the ... State of Legal Marijuana Markets Report  from from ArcView ... much of the increase in sector is attributed to ...
(Date:5/25/2016)... , May 25, 2016 ... the precision of circulating tumour DNA (ctDNA) analysis ... the appointment of Professor Clive Morris ... leadership across the clinical development programme, scientific collaborations, ... help deliver significant improvements in clinical outcomes for ...
Breaking Medicine Technology: